Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (71-80 of 223) with videos related to

Pageof 23
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-AnalysisAlberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
The Lancet. Oncology|May 21, 2013
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trialDino Amadori, Massimo Aglietta, Barbara Alessi, et al.
Medicine|November 18, 2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literatureAlberto Bongiovanni, Federica Recine, Monica Celli, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni, et al.
Molecules (Basel, Switzerland)|December 6, 2016
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic SarcomaAlessandro De Vita, Giacomo Miserocchi, Federica Recine, et al.
Pathology, Research and Practice|January 30, 2023
Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature reviewValli de la Guardia, Ahmed Atherley O'Meally, Marco Gambarotti, et al.
Cells|October 28, 2018
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell LineGiacomo Miserocchi, Alessandro De Vita, Laura Mercatali, et al.
Therapeutic Advances in Medical Oncology|February 17, 2018
Myxofibrosarcoma primary cultures: molecular and pharmacological profileAlessandro De Vita, Federica Recine, Laura Mercatali, et al.
Journal of Visualized Experiments : Jove|May 1, 2018
Establishment of a Primary Culture of Patient-derived Soft Tissue SarcomaAlessandro De Vita, Laura Mercatali, Giacomo Miserocchi, et al.
Pageof 23

Showing results (71-80 of 223) with videos related to

Sort By:
Pageof 23
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-AnalysisAlberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
The Lancet. Oncology|May 21, 2013
Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trialDino Amadori, Massimo Aglietta, Barbara Alessi, et al.
Medicine|November 18, 2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literatureAlberto Bongiovanni, Federica Recine, Monica Celli, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni, et al.
Molecules (Basel, Switzerland)|December 6, 2016
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic SarcomaAlessandro De Vita, Giacomo Miserocchi, Federica Recine, et al.
Pathology, Research and Practice|January 30, 2023
Osteogenic sarcomas of the hands: A case series with emphasis in its peculiarities and literature reviewValli de la Guardia, Ahmed Atherley O'Meally, Marco Gambarotti, et al.
Cells|October 28, 2018
Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell LineGiacomo Miserocchi, Alessandro De Vita, Laura Mercatali, et al.
Therapeutic Advances in Medical Oncology|February 17, 2018
Myxofibrosarcoma primary cultures: molecular and pharmacological profileAlessandro De Vita, Federica Recine, Laura Mercatali, et al.
Journal of Visualized Experiments : Jove|May 1, 2018
Establishment of a Primary Culture of Patient-derived Soft Tissue SarcomaAlessandro De Vita, Laura Mercatali, Giacomo Miserocchi, et al.
Pageof 23